Antimicrobial therapy for Bacillus anthracis-induced polymicrobial infection in 60Co γ-irradiated mice

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3463-3471

  Elliott, Thomas B ^a   Brook, Itzhak ^a   Harding, Rita A ^a   Bouhaouala, S Samy ^a   Shoemaker, Michael O ^a   Knudson, Gregory B ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; COBALT 60; ERYTHROMYCIN; GATIFLOXACIN; OFLOXACIN; PROCAINE PENICILLIN; TROVAFLOXACIN;

ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIAL SPORE; CHRONOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GAMMA IRRADIATION; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ADMINISTRATION, ORAL; ANIMALS; ANTHRAX; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; FEMALE; FLUOROQUINOLONES; GAMMA RAYS; INJECTIONS, SUBCUTANEOUS; MACROLIDES; MICE; MICE, INBRED STRAINS; MICROBIAL SENSITIVITY TESTS; PENICILLIN G, PROCAINE; PENICILLINS; SURVIVAL ANALYSIS; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 0036839748     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3463-3471.2002     Document Type: Article

References (41)

1. Abramova, F. A., L. M. Grinberg, O. V. Yarnpolskaya, D. H. Walker. 1993. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc. Natl. Acad. Sci. USA 90:2291-2294.
2. Andes, D. R., and W. A. Craig. 1998. Pharmacodynamics of fluoroquinolones in experimental models of endocarditis. Clin. Infect. Dis. 27:47-50.
3. Andes, D. R., and W. A. Craig. 2002. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrob. Agents Chemother. 46:1665-1670.
4. Brook, I., and T. B. Elliott. 1991. Quinolone therapy in the prevention of mortality after irradiation. Radial. Res. 128:100-103.
5. Brook, I., and T. B. Elliott. 1989. Treatment of wound sepsis in irradiated mice. Int. J. Radiat. Biol. 56:75-82.
6. Brook, I., T. B. Elliott, R. A. Harding, S. S. Bouhaouala, S. J. Peacock, G. D. Ledney, and G. B. Knudson. 2001. Susceptibility, of irradiated mice to Bacillus anthracis Sterne by the intratracheal route of infection. J. Med. Microbiol. 50:702-711.
7. Brook, I., T. B. Elliott, and G. D. Ledney. 1999. Infection after ionizing irradiation, p. 151-161. In O. Zak and M. A. Sande (ed.), Handbook of animal models of infection: experimental models in antimicrobial chemotherapy. Academic Press, Inc., San Diego, Calif.
8. Brook, I., T. B. Elliott, and G. D. Ledney. 1990. Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin. Radiat. Res. 122:215-217.
9. Brook, I., T. B. Elliott, H. I. Pryor, I. I., T. E. Sautter, B. T. Gnade, J. H. Thakar, and G. B. Knudson. 2001. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides, and quinolones. Int. J. Antimicrob. Agents 18:559-562.
10. Brook, I., and G. D. Ledney. 1992. Quirolone therapy in the management of infection after irradiation. Crit. Rev. Microbiol. 18:235-246.
11. Carter, R. E., and D. M. Verrelli. 1973. AFRRI cobalt whole-body irradiator. Technical Note 73-3. Armed Forces Radiobiology Research Institute, Bethesda, Md.
12. Choe, C. H., S. S. Bouhaouala, I. Brook, T. B. Elliott, and G. B. Knudson. 2000. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrob. Agents Chemother. 44:1766.
13. Craig, W. A. 1995. Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA. Eur. J. Clin. Microbiol. Infect. Dis. 14:636-642.
14. Craig, W. A. 2001. Does the dose matter? Clin. Infect. Dis. 33(Suppl. 3): S233-S237.
15. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-12.
16. Dalldorf, F. G., and F. A. Beall. 1967. Capillary thrombosis as a cause of death in experimental anthrax. Arch. Pathol. 83:154-161.
17. Dixon, T. C., M. Meselson, J. Guillemin, and P. C. Hanna. 1999. Anthrax. N. Engl. J. Med. 341:815-826.
18. Elliott, T. B., I. Brook, and S. M. Stiefel. 1990. Quantitative study of wound infection in irradiated mice. Int. J. Radiat. Biol. 58:341-350.
19. Elliott, T. B., G. D. Ledney, R. A. Harding, P. L. Henderson, H. M. Gerstenberg, J. R. Rotruck, M. H. Verdolin, C. M. Stille, and A. G. Krieger. 1995. Mixed-field neutrons and γ photons induce different changes in ileal bacteria and correlated sepsis in mice. Int. J. Radiat. Biol. 68:311-320.
20. Elliott, T. B., G. S. Madonna, G. D. Ledney, and I. Brook. 1989. Combined therapy for postirradiation infection. Microecol. Ther. 19:105-108.
21. Franz, D. R., P. B. Jahrling, A. M. Friedlander, D. J. McClain, D. L. Hoover, W. R. Bryne, J. A. Pavlin, G. W. Christopher, and E. M. Eitzen, Jr. 1997. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399-411.
22. Freireich, E. J., E. A. Gehan, D. P. Rail, L. H. Schimdt, and H. E. Skipper. 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50:219-244.
23. Friedlander, A. M., S. L. Welkos, M. L. M. Pitt, J. W. Ezzell, P. L. Worsham, K. J. Rose, B. E. Ivins, J. R. Lowe, G. B. Howe, P. Mikesell, and W. B. Lawrence. 1993. Postexposure prophylaxis against experimental inhalationn anthrax. J. Infect. Dis. 167:1239-1242.
24. Grosset, J. H. 1994. Assessment of new therapies for infection due to the Mycobacterium avium complex: appropriate use of in vitro and in vivo testing. Clin. Infect. Dis. 18:S233-S236.
25. Ingelsby, T. V., D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. M. Eitzen, A. M. Friedlander, J. Hauer, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, and K. Tonat. 1999. Anthrax as a biological weapon: medical and public health management. JAMA 281:1735-1745.
26. Institute of Laboratory Animal Resources, National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
27. Klein, F., J. S. Walker, D. F. Fitzpatrick, R. E. Lincoln, B. G. Mahlandt, W. I. Jones, Jr., J. P. Dobbs, and K. J. Hendrix. 1966. Pathophysiology of anthrax. J. Infect. Dis. 116:123-138.
28. Knudson, G. B. 1986. Treatment of anthrax in man: history and current concepts. Milit. Med. 151:71-77.
29. Lalitha, M. K., and M. K. Thomas. 1997. Penicillin resistance in Bacillus anthracis. Lancet 349:1522.
30. Ledney, G. D., T. B. Elliott, M. R. Landauer, R. M. Vigneulle, P. L. Henderson, R. A. Harding, and S. P. Tom, Jr. 1994. Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin. Adv. Space Res. 14:583-586.
31. Madonna, G. S., G. D. Ledney, T. B. Elliott, I. Brook, J. T. Ulrich, K. R. Meyers, M. L. Patchen, and R. I. Walker. 1989. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect. Immun. 57:2495-2501.
32. Miyazaki, S., T. Fujikawa, T. Matsumoto, K. Tateda, and K. Yamaguchi. 2001. Efficacy of azithromycin, clarithromycin and β-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. J. Antimicrob. Chemother. 48:425.430.
33. Ng, W., I. Lutsar, L. Wubbel, F. Ghaffar, H. Jafri, G. H. McCracken, and I. R. Friedland. 1999. Pharmacodynamics of trovafloxacin in a mouse model of ecphalosporin-resistant Streptococcus pneumoniae pneumonia. J. Antimicrob. Chemother. 43:811-816.
34. Patchen, M. L., I. Brook, T. B. Elliott, and W. E. Jackson. 1993. Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy. Antimicrob. Agents Chemother. 37:1882-1889.
35. Peterson, V. M., J. J. Adamovicz, T. B. Elliott, M. M. Moore, G. S. Madonna, W. E. Jackson III, G. D. Ledney, and W. C. Gause. 1994. Gene expression of hematoregulatory cytokines is elevated endogenously following sublethal γ-irradiation and is differentially enhanced by therapeutic administration of biological response modifiers. J. Immunol. 153:2321-2330.
36. Pile, J. C., J. D. Malone, E. M. Eitzen, and A. M. Friedlander. 1998. Anthrax as a potential biological warfare agent. Arch. Intern. Med. 158:429-434.
37. Schaeffer, P., J. Millet, and J.-P. Aubert. 1965. Catabolic repression of bacterial sporulation. Proc. Natl. Acad. Sci. USA 54:704-711.
38. Tessier, P. R., M.-K. Kim, W. Zhou, D. Xuan, C. Li, M. Ye, C. H. Nightingale, and D. P. Nicolau. 2002. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. Antimicrob. Agents Chemother. 46:1425-1434.
39. Welkos, S. L., and A. M. Friedlander. 1988. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb. Pathog. 4:53-69.
40. Welkos, S. L., T. J. Keener, and P. H. Gibbs. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51:795-800.
41. Whitnall, M. H., T. B. Elliott, R. A. Harding, C. E. Inal, M. R. Landauer, C. L. Wilhelmsen, L. McKinney, V. L. Miner, William E. Jackson III, R. M. Loria, G. D. Ledney, and T. M. Seed. 2000. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int. J. Immunopharmacol. 22:1-14.